Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T13:37:39.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A notice announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence,” while both terms may appear during the transition.
    Difference
    0.7%
    Check dated 2026-10-24T17:06:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site as revision v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T16:54:29.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision identifier changed from v3.7.0 to v3.7.1. The study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T17:47:41.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 was added and the previous tag v3.6.6 was removed, signaling an update to the study record's version.
    Difference
    0.1%
    Check dated 2026-09-19T20:23:31.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing v3.6.5, indicating a new version of the page in the history.
    Difference
    0.1%
    Check dated 2026-08-29T18:36:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.